Three things more presidential than bashing pharmaceutical manufacturers

Curant COO, Marc O’Connor, was recently featured in Specialty Pharmacy Times in a piece that highlights the futility of presidential candidates focusing strictly on pharmaceutical manufacturers as the primary source of healthcare’s woes. It is true that companies such as Turing Pharmaceutical have the ability to cause a strong negative domino effect on patients with pricing… read more

Treating an HIV and Hepatitis C Co-infection Takes Therapies, Adherence and Hope

Being diagnosed with an illness such as hepatitis C can be shocking for some, to say the least. Receiving a diagnosis of HIV and hepatitis C co-infection can be life-altering. According to the Centers for Disease Control and Prevention (CDC): 25% of patients living with HIV in the U.S. are co-infected with hepatitis C 80% of… read more

Advancing hepatitis C treatments and therapies

Hepatitis C is not a new chronic illness, but many people fail to realize how grave the illness is; on some levels, hepatitis C can be compared to HIV in terms of how serious this illness is. There are some interesting and somewhat shocking statistics you may not know about hepatitis C. An estimated 3.2… read more

Healthcare in 2015 review, 2016 expectations

As 2015 winds down, this would be an opportune time to look at learnings from the last year within the healthcare industry, as well as the future insights from healthcare stakeholders. Curant Health COO, Marc O’Connor, gives his insights on developments providers, manufacturers and payers have seen this year and where future developments will take them… read more

Improving HIV Care & Medication Management Where It’s Needed Most

At the end of 2010, the American South accounted for 45% of the estimated 33,015 new AIDS diagnoses in the 50 states and the District of Columbia, followed by the Northeast (24%), the West (19%), and the Midwest (13%).1 On the front lines of this epidemic, The University of Alabama-Birmingham 1917 Clinic serves more than… read more

2016 Trends in top therapies, including HIV treatments

Recently, there has been buzz on the top therapeutic areas to watch for in the healthcare world in 2016. In a recent edition of Managed Healthcare Executive, Curant COO Marc O’Connor gives his perspective on a few upcoming hot healthcare hot topics for next year. Prominent categories of healthcare quickly becoming the center of attention… read more

Media contact: Kristin Lindsey, Marketing Director at 866-437-8040, extension 253 or

Menu Title